Granules India Limited Guaifenesin Export Data — India (DGFT 2022–2026)

Name: Granules India Limited Guaifenesin Export Records India — #1 Exporter, 181 Shipments, $9.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Guaifenesin

India Pharmaceutical Trade Intelligence

$26.7M151 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES69.6%India → IRAQ3.4%

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Granules India Limited — Guaifenesin Exporter #1 | $9.1M Trade Value | TransData Nexus | TransData Nexus

Granules India Limited — Guaifenesin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Guaifenesin · $9.1M export value · DGFT Verified

Granules India Limited is the #1 Indian exporter of Guaifenesin with $9.1M in export value and 181 verified shipments. Granules India Limited holds a 33.9% market share in Guaifenesin exports across 2 countries. The company exports 20 pharmaceutical products worth $412.3M across 9 therapeutic categories.

Granules India Limited — Guaifenesin Export Profile: Buyers & Destinations

Granules India Limited Guaifenesin export treemap — buyers and destination countries | TransData Nexus

Where Does Granules India Limited Export Guaifenesin?

Country	Value	Shipments	Share
UNITED STATES	$6.6M	177	99.0%
UNITED STATES OF AMERICA	$68.0K	2	1.0%
JORDAN	$36	2	0.0%

Granules India Limited exports Guaifenesin to 3 countries. The largest destination is UNITED STATES accounting for 99.0% of Granules India Limited's Guaifenesin shipments, followed by UNITED STATES OF AMERICA (1.0%) and JORDAN (0.0%). These destinations reflect Granules India Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Guaifenesin from Granules India Limited?

Buyer	Country	Value	Orders
GRANULES CONSUMER HEALTH	UNITED STATES	$4.3M	116
GRANULES USA INC.	UNITED STATES	$697.1K	25
PERRIGO COMPANY	UNITED STATES	$600.0K	12
GRANULES USA INC	UNITED STATES	$559.6K	15
PERRIGO COMPANY PLANT	UNITED STATES	$250.0K	5
GRANULES CONSUMER HEALTH, LLC	UNITED STATES	$186.8K	4
GRANULES CONSUMER HEALTH LLC	UNITED STATES	$50.0K	1
GRANULES USA A DIVISION OF	UNITED STATES	$42.0K	1
TO TRIUMPHARMA ATT	JORDAN	$36	2

Granules India Limited supplies Guaifenesin to 9 buyers globally. The largest buyer is GRANULES CONSUMER HEALTH (UNITED STATES), followed by GRANULES USA INC. (UNITED STATES) and PERRIGO COMPANY (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Guaifenesin Formulations Does Granules India Limited Export?

Product Description / Formulation	Value	Shipments
Guaifenesin Extended Release Tablets 120	$500.0K	10
GUAIFENESIN EXTENDED RELEASE TABLETS 600MG	$450.8K	12
GUAIFENESIN EXTENDED RELEASE TABLETS 600	$360.2K	10
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG	$349.9K	8
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14'S	$300.0K	6
GUAIFENESIN EXTENDED RELEASE TABLETS 120	$289.3K	8
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MGNOS	$204.4K	6
GUAIFENESIN EXTENDED-RELEASE TABLETS 600MGNOS	$154.7K	6
Guaifenesin Extended Release Tablets 1200mg 14s/Perrigo	$150.0K	3
GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14S(201,000.000PAC)	$150.0K	3

Granules India Limited exports 84 distinct Guaifenesin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Guaifenesin Extended Release Tablets 120 with 10 shipments worth $500.0K.

How Does Granules India Limited Compare to Nearest Guaifenesin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	GRANULES INDIA LIMITED ★	$9.1M	181	2	$50.0K
2	ELYSIUM PHARMACEUTICALS LTD	$3.9M	77	1	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$899.7K	31	1	$29.0K

Granules India Limited ranks #1 among 151 Indian Guaifenesin exporters. Average shipment value of $50.0K compared to the market average of $131.8K. The closest competitors by value are ELYSIUM PHARMACEUTICALS LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Guaifenesin Exports?

Port	Shipments	% Share
HYDERABAD ICD	118	11.2%
NHAVA SHEVA SEA (INNSA1)	94	9.0%
JNPT	74	7.0%
JNPT/ NHAVA SHEVA SEA	70	6.7%
HYDERABAD AIR	53	5.0%
HYDERABAD ICD (INSNF6)	50	4.8%
MUNDRA SEA (INMUN1)	50	4.8%
MUNDRA SEA	47	4.5%

Geopolitical & Trade Policy Impact on Granules India Limited's Guaifenesin Exports

Granules India's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, compelling maritime carriers to reroute via the Cape of Good Hope. This has resulted in increased lead times and freight costs, posing challenges for time-sensitive pharmaceutical shipments. To mitigate these risks, Granules India is leveraging its multi-site manufacturing capabilities and strategic inventory positioning. (pharmaceuticalcommerce.com)

The U.S.-China trade tensions have created opportunities for Indian pharmaceutical exporters like Granules India, as global buyers seek to diversify their supply chains. However, compliance with evolving U.S. pharmaceutical import policies remains crucial. In the European Union, the implementation of the Falsified Medicines Directive necessitates stringent serialization and traceability measures. Granules India's proactive approach to regulatory compliance positions it favorably to navigate these complexities and maintain its export momentum.

Granules India Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Granules India, given its extensive export operations. The company's Gagillapur facility in Telangana received a warning letter from the U.S. Food and Drug Administration (FDA) in February 2025, following an inspection that identified issues related to equipment maintenance and contamination control. In response, Granules India implemented comprehensive corrective and preventive actions, including engaging independent consultants and enhancing cleaning protocols. The company has been providing regular updates to the FDA and is prepared for re-inspection to demonstrate compliance. (moneycontrol.com)

Conversely, Granules India's U.S.-based packaging facility in Virginia successfully cleared an FDA inspection in December 2025 with zero observations, reflecting the company's commitment to quality and regulatory excellence. (pharma.economictimes.indiatimes.com)

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Granules India Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 181 individual customs records matching Granules India Limited exporting Guaifenesin, covering 84 formulations to 3 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 77+ countries, 278+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Guaifenesin

Guaifenesin

Granules India Limited — Guaifenesin Exporter Profile

Granules India Limited — Guaifenesin Export Profile: Buyers & Destinations

Where Does Granules India Limited Export Guaifenesin?

Who Are the Top Buyers of Guaifenesin from Granules India Limited?

What Is India's Total Guaifenesin Export Value and How Much Does Granules India Limited Contribute?

What Is the Average Shipment Value for Granules India Limited's Guaifenesin Exports?

How Does Granules India Limited Compare to Other Indian Guaifenesin Exporters?

What Guaifenesin Formulations Does Granules India Limited Export?

Regulatory Requirements: Exporting Guaifenesin to Key Markets

United States — FDA

How Does Granules India Limited Compare to Nearest Guaifenesin Exporters?

Which Indian Ports Ship Guaifenesin Exports?

What Other Respiratory & OTC Products Does Granules India Limited Export?

Geopolitical & Trade Policy Impact on Granules India Limited's Guaifenesin Exports

Granules India Limited — Regulatory Compliance & Quality Standards

About Granules India Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Guaifenesin Export Data from Granules India Limited

Guaifenesin Stats

Company Overview

Top Products by Granules India Limited

Related Analysis

Need Detailed Export Data?

Data Source